FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denisova, G.
Right arrow Articles by Gershoni, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denisova, G.
Right arrow Articles by Gershoni, J. M.

The FASEB Journal, Vol 9, 127-132, Copyright © 1995 by The Federation of American Societies for Experimental Biology


RESEARCH COMMUNICATIONS

Binding of HIV-1 gp120 to an anti-V3 loop antibody reveals novel antigen-induced epitopes

G Denisova, J Zwickel and JM Gershoni
Department of Cell Research and Immunology, George S. Wise Faculty of Life Science, Tel Aviv University, Israel.

Antigen association to its corresponding binding site in the immunoglobulin molecule can elicit conformational rearrangements, generating novel epitopes termed metatopes. Such metatopes were characterized for the immunocomplex between the AIDS virus envelope protein, gp120, and M77, a mAb directed against the V3 loop. Five novel mAbs were described (GV1, GV3, GV7, GV8, and GV12). These mAbs were found to bind epitopes harbored in the M77 Fab fragment. Binding to the epitopes was shown to require the complexation of Fab with its antigen. The degree of this antigen requirement was found to be variable for the different mAbs and also for the state of IgG fragmentation. Binding of GV12 to its antigen increased the affinity of M77 for gp120. Moreover, in the presence of GV12, M77 acquired extended cross-reactivity for a second gp120 variant, namely BaL. These results could indicate a novel approach towards improving the performance of anti-HIV antibodies.


This article has been cited by other articles:


Home page
FASEB J.Home page
D. ENSHELL-SEIJFFERS, L. SMELYANSKI, N. VARDINON, I. YUST, and J. M. GERSHONI
Dissection of the humoral immune response toward an immunodominant epitope of HIV: a model for the analysis of antibody diversity in HIV+ individuals
FASEB J, October 1, 2001; 15(12): 2112 - 2120.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Modur, G. A. Zimmerman, S. M. Prescott, and T. M. McIntyre
Endothelial Cell Inflammatory Responses to Tumor Necrosis Factor alpha . CERAMIDE-DEPENDENT AND -INDEPENDENT MITOGEN-ACTIVATED PROTEIN KINASE CASCADES
J. Biol. Chem., May 31, 1996; 271(22): 13094 - 13102.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Carrero, W. D. Mallender, and E. W. Voss Jr.
Anti-metatype Antibody Stabilization of Fv 4-4-20 Variable Domain Dynamics
J. Biol. Chem., May 10, 1996; 271(19): 11247 - 11252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by The Federation of American Societies for Experimental Biology.